Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Medical Devices

Overview

We partner with medical device manufacturers in the U.S. and abroad to bring revolutionary products to market, navigate industry regulations, protect designs, drive business growth, and enhance and execute overall business strategies. Our regulatory counsel team manages interactions with governmental agencies, including the Centers for Medicaid and Medicare Services and the Food and Drug Administration, and our government affairs professionals help to identify and mobilize strategies for prompt product approvals and to respond to the challenges and capitalize on the opportunities presented by new regulations and changes in the marketplace. Whether developing a new product, seeking to enter a new market or pursuing a strategic acquisition or affiliation, our regulatory, corporate, transactional and IP attorneys leverage industry-specific insights to help medical device companies advance their goals.

Insights & Events

Latest

Updates October 2025

FDA Requests Public Comment on Metrics and Methods for Evaluating Performance of AI-Driven Medical Devices Deployed in Clinical Settings

Written Responses Due by December 1, 2025
3 min read
Updates August 2025

The EU Data Act: Impact on Connected Products and Device Manufacturers

Any Organisation Established Outside the EU but Operating in the EU Market Will Potentially Fall Within Scope
14 min read
Updates August 2025

Effects of the One Big Beautiful Bill Act on Health Care and Pharma; and More

Biopharma & Medical Devices Briefing
7 min read
Press Release July 2025

Faegre Drinker Continues Product Liability Growth in New York, Adding Counsel Alena Markley

2 min read
Media Mentions June 2025

Bench & Bar of Minnesota Highlights New MSBA President Tom Pack’s Approach to Leadership

1 min read
News June 2025

The Legal 500 United States 2025 Guide Recognizes Faegre Drinker Practices

2 min read
Updates June 2025

Future Damages and Future Injunction May Constitute Double Recovery in Trade Secrets Case

Insulet Corporation v. EO Flow Co., Ltd.
4 min read
Speaking Engagement Recap May 16, 2025

AI Policy and the New Administration: Implications for FDA-Regulated Industries

2025 FDLI Annual Conference
1 min read
Updates May 2025

Is This the Death Knell of Strict Liability Crimes?

The Impact of President Trump’s May 9, 2025, Executive Order on Regulatory Criminal Offenses & FDCA Enforcement
10 min read
Speaking Engagement Recap December 12, 2024

ATA’s EDGE 2024 Policy Conference

1 min read
Insights
Updates October 2025

FDA Requests Public Comment on Metrics and Methods for Evaluating Performance of AI-Driven Medical Devices Deployed in Clinical Settings

Written Responses Due by December 1, 2025
3 min read
Updates August 2025

The EU Data Act: Impact on Connected Products and Device Manufacturers

Any Organisation Established Outside the EU but Operating in the EU Market Will Potentially Fall Within Scope
14 min read
Updates August 2025

Effects of the One Big Beautiful Bill Act on Health Care and Pharma; and More

Biopharma & Medical Devices Briefing
7 min read
Media Mentions June 2025

Bench & Bar of Minnesota Highlights New MSBA President Tom Pack’s Approach to Leadership

1 min read
Updates June 2025

Future Damages and Future Injunction May Constitute Double Recovery in Trade Secrets Case

Insulet Corporation v. EO Flow Co., Ltd.
4 min read
Updates May 2025

Is This the Death Knell of Strict Liability Crimes?

The Impact of President Trump’s May 9, 2025, Executive Order on Regulatory Criminal Offenses & FDCA Enforcement
10 min read
Media Mentions May 2025

Barrett Tenbarge Provides Insights on FDA Staffing Cuts for Chemical & Engineering News

1 min read
Updates May 2025

HHS and FDA Launch RFI on Deregulatory Plan — A Key Opportunity to Shape Health and Food Policy

Submissions Through Regulations.gov Due July 14, 2025
4 min read
Updates April 2025

The Effects of HHS Workforce Reductions, Tariffs on Pharma, the ‘Pill Penalty’ and More

Biopharma & Medical Devices Briefing
5 min read
Updates April 2025

Comment Period Open for Massive New PFAS Reporting Requirements in Minnesota

Deadline for Written Comments Is May 21, 2025
3 min read

Meet The Team

Meet The Full Medical Devices Team